An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Jyoti Wadhwa ( Moderator ) ,Dr Atul Sharma ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Srujna Joga ( Expert Panel )

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

In this webinar, a detailed discussion is done on CROWN trial update: Optimizing 1st-line ALK+ mNSCLC management.

Speakers : Dr Srujna Joga ( Expert Panel ) ,Dr AP Dubey ( Expert Panel ) ,Dr Atul Sharma ( Expert Panel ) ,Dr Jyoti Wadhwa ( Moderator )

Efficient Management of First line ALK-rearranged NSCLC

In this webinar, a detailed discussion is done on the efficient management of first line ALK rearranged NSCLC.

Speakers : Dr B K ,Dr Abhishek Kakroo ,Dr Jogamaya Pattnaik

Efficient Management of First line ALK-rearranged NSCLC - Part V

Explore optimal first-line strategies for ALK-rearranged NSCLC to enhance survival and manage resistance.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti

Efficient Management of First line ALK-rearranged NSCLC - Part IV

Explore optimal first-line strategies and targeted therapies for managing ALK-rearranged non-small cell lung cancer.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti

Efficient Management of First line ALK-rearranged NSCLC - Part III

Explore optimal first-line strategies for managing ALK-rearranged NSCLC with advanced targeted therapies and clinical insights.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti

Efficient Management of First line ALK-rearranged NSCLC - Part II

Discover effective first-line strategies for managing ALK-rearranged NSCLC using targeted therapies and personalized treatment approaches.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti

Efficient Management of First line ALK-rearranged NSCLC - Part VI

In this webinar, a detailed discussion is done on the efficient management of first line ALK rearranged NSCLC.

Speakers : Dr Jogamaya Pattnaik

Efficient Management of First line ALK-rearranged NSCLC - Part VII

Explore first-line management strategies and targeted therapies for ALK-rearranged NSCLC to optimize patient outcomes.

Speakers : Dr Jogamaya Pattnaik ,Dr Abhishek Kakroo ,Dr B K Smruti


Recommended News For You

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

Which women need more than mammograms for breast cancer screening?

Recommended Articles For You

Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans 

Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease 

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances 

Smart Chemotherapy Chair Monitoring Infrastructure: Clinical Applications, Safety, and Future Directions 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer during young adulthood carries long-term mental toll, study finds

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

1.

Exploring New Treatment Strategies for Mantle Cell Lymphoma

2.

Essential Techniques in Oncology and Quality Improvement

3.

Molecular Matching for Complex Blood Disorders

4.

Risk Assessment of Reduced Hematopoietic Reserve During Chronic Systemic Stress

5.

Oncology Team Communication Training for Clinical Learners

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

2.

Breast Cancer Awareness and Early Detection

3.

How Advances in Cancer Research Are Improving Treatment Options

4.

Hands-on Workshop: Hematology

5.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot